Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping

候选人资格声明 这个多元化补充申请的目标是为艾利森博士提供职业发展支持 希克曼，一个生物信息学家谁渴望（并与支持可以执行）的领导作用，在商业 科学妇女在科学领导层中的代表性不足，特别是在生物信息学领域， 这个奖项将通过支持一个真正有才华的人来正式解决这个问题。希克曼博士是美国人 公民和EpiCypher公司的全职员工，小型企业关注（SBC）有资格提交申请 美国国立卫生研究院EpiCypher最近获得了NHGRI的SBIR快速通道资助 [R44 HG 011875]，目前处于第一年（三年），有资格获得多样性补充支持。 5.12.2022 博士Allison Hickman -多样性补充候选人（研究科学家）日期 5.11.2022 博士Martis Cowles - EpiCypher签约官（首席商务官）日期

Candidate Eligibility Statement The goal of this diversity supplement application is to provide career development support for Dr. Allison Hickman, a bioinformatician who aspires to (and with support could perform) leadership roles in commercial science. Women have been under-represented in science leadership, particularly in the field of bioinformatics, and this award would formally address the issue by supporting a truly talented individual. Dr. Hickman is a US citizen and full-time employee at EpiCypher Inc., a Small Business Concern (SBC) eligible to submit applications to the National Institutes of Health. EpiCypher was recently awarded an SBIR Fast-Track Grant from NHGRI [R44 HG011875] that is currently in year one (of three) and is eligible for diversity supplement support. 5.12.2022 Dr. Allison Hickman - Diversity Supplement Candidate (Research Scientist) Date 5.11.2022 Dr. Martis Cowles - EpiCypher Signing Official (Chief Business Officer) Date